Passive Biotech Equities

iShares Biotechnology ETF

The iShares Biotechnology ETF (the “Fund”) seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

$124.64

+1.8% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Biotechnology ETF IBB
Fund Size
$8.24 Billion
Dividend
0.3%
Fees
0.44%
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.3%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.2%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.3%
Fees
0.03%
View 1287 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $44.9 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.59 %
Beta Indicates the relationship between the price performance of a share and the market. 0.7582
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 31.05
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -15.74
Profitable Companies 59
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 177.69
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.94
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 0.0
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 12.65
Enterprise Value to Revenue Enterprise value divided by revenue 93.95
Total Debt to Enterprise Value Total debt divided by enterprise value 0.11
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.8745
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1895.88%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 1.17%
Return on Assets Indicates a company's profitability in relation to its total assets. -1.71%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 0.70%

Industries

Healthcare 87.9%
Other 6.1%
Materials 0.4%
N/A 5.6%

Market cap

Micro Cap 3%
Small Cap 8%
Mid Cap 18%
Large Cap 70%
Mega Cap 0%

231 Investments

P/E-Ratio
Total Investment
Weight
BlackRock Funds III logo

BlackRock Funds III

P/E-Ratio
n/a
Total Investment
$783 Million
Weight
10.5%
Vertex Pharmaceuticals, Inc. logo

VRTX - Manufacturing

Vertex Pharmaceuticals, Inc.

P/E-Ratio
28.6
Total Investment
$634 Million
Weight
8.5%
Amgen, Inc. logo

AMGN - Manufacturing

Amgen, Inc.

P/E-Ratio
21.5
Total Investment
$590 Million
Weight
7.9%
Regeneron Pharmaceuticals, Inc. logo

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

P/E-Ratio
25.1
Total Investment
$589 Million
Weight
7.9%
Gilead Sciences, Inc. logo

GILD - Manufacturing

Gilead Sciences, Inc.

P/E-Ratio
15.1
Total Investment
$585 Million
Weight
7.8%
IQVIA Holdings, Inc. logo

IQV - Health Care and Social Assistance

IQVIA Holdings, Inc.

P/E-Ratio
31.8
Total Investment
$299 Million
Weight
4.0%
Biogen, Inc. logo

BIIB - Manufacturing

Biogen, Inc.

P/E-Ratio
25.5
Total Investment
$278 Million
Weight
3.7%
Moderna, Inc. logo

MRNA - Manufacturing

Moderna, Inc.

P/E-Ratio
-8.7
Total Investment
$246 Million
Weight
3.3%
Mettler-Toledo International, Inc. logo

MTD - Manufacturing

Mettler-Toledo International, Inc.

P/E-Ratio
35.6
Total Investment
$193 Million
Weight
2.6%
Alnylam Pharmaceuticals, Inc. logo

ALNY - Manufacturing

Alnylam Pharmaceuticals, Inc.

P/E-Ratio
-43.5
Total Investment
$179 Million
Weight
2.4%
Illumina, Inc. logo

ILMN - Manufacturing

Illumina, Inc.

P/E-Ratio
-17.9
Total Investment
$164 Million
Weight
2.2%
Waters Corp. logo

WAT - Manufacturing

Waters Corp.

P/E-Ratio
31.1
Total Investment
$145 Million
Weight
1.9%
BioNTech SE logo

BNTX - Manufacturing

BioNTech SE

P/E-Ratio
20.1
Total Investment
$139 Million
Weight
1.9%
BioMarin Pharmaceutical, Inc. logo

BMRN - Manufacturing

BioMarin Pharmaceutical, Inc.

P/E-Ratio
103.0
Total Investment
$133 Million
Weight
1.8%
Argenx SE logo

ARGX - Manufacturing

Argenx SE

P/E-Ratio
0.0
Total Investment
$121 Million
Weight
1.6%
Genmab A/S logo

GMAB - Professional, Scientific, and Technical Services

Genmab A/S

P/E-Ratio
0.0
Total Investment
$114 Million
Weight
1.5%
Incyte Corp. logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp.

P/E-Ratio
20.6
Total Investment
$104 Million
Weight
1.4%
Neurocrine Biosciences, Inc. logo

NBIX - Manufacturing

Neurocrine Biosciences, Inc.

P/E-Ratio
54.2
Total Investment
$93.9 Million
Weight
1.3%
BeiGene Ltd. logo

BGNE - Manufacturing

BeiGene Ltd.

P/E-Ratio
-15.8
Total Investment
$92.4 Million
Weight
1.2%
Bio-Techne Corp. logo

TECH - Manufacturing

Bio-Techne Corp.

P/E-Ratio
48.3
Total Investment
$90.1 Million
Weight
1.2%
Charles River Laboratories International, Inc. logo

CRL - Professional, Scientific, and Technical Services

Charles River Laboratories International, Inc.

P/E-Ratio
26.7
Total Investment
$88.7 Million
Weight
1.2%
Karuna Therapeutics, Inc. logo

KRTX - Manufacturing

Karuna Therapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$76 Million
Weight
1.0%
United Therapeutics Corp. logo

UTHR - Manufacturing

United Therapeutics Corp.

P/E-Ratio
11.3
Total Investment
$75.2 Million
Weight
1.0%
Repligen Corp. logo

RGEN - Manufacturing

Repligen Corp.

P/E-Ratio
236.5
Total Investment
$69.7 Million
Weight
0.9%
Sarepta Therapeutics, Inc. logo

SRPT - Manufacturing

Sarepta Therapeutics, Inc.

P/E-Ratio
-21.8
Total Investment
$63.5 Million
Weight
0.9%